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Long-term Results and Recurrence-Related Risk Factors
for Crohn Disease in Patients Undergoing Side-to-Side
Isoperistaltic Strictureplasty
Marilena Fazi, MD; Francesco Giudici, MD, PhD; Cristina Luceri, PhD; Micaela Pronestì, MD; Francesco Tonelli, MD
IMPORTANCE Side-to-side isoperistaltic strictureplasty (SSIS) is useful in patients undergoing
surgery for Crohn disease (CD) to avoid wide small-bowel resections. To our knowledge, there
are no definitive data regarding its recurrence risk factors.
OBJECTIVE To evaluate the results obtained in a monocentric population of patients with CD
who have undergone SSIS.
DESIGN, SETTING, AND PARTICIPANTS FromAugust 1996 toMarch 2010, 91 patients with CD
underwent SSIS in our center. In this prospective observational study, side-to-side
isoperistaltic strictureplasty was according theMichelassi technique in 69 patients and the
Tonelli technique in 22 patients. Factors relating to the patient and the CD, surgery, and
pharmacological therapy during the preoperative and perioperative periods were evaluated
in association with medical or surgical recurrence.
EXPOSURE Side-to-side isoperistaltic strictureplasty.
MAIN OUTCOMES ANDMEASURES The recurrence-free curvewas estimated using
Kaplan-Meier analysis. Patients were stratified into cohorts in relation to the considered
categorical variables and data were compared by using theMantel-Cox log-rank test. Cox
proportional hazard regression analysis was used to set up a predictive model simultaneously
exploring the effects of all independent variables on a dichotomous outcome recurrence in
relation to time.
RESULTS Among the 91 patients, the mean (SD) age was 39.5 (11.2) years and preoperative
disease duration was 97.9 (85.8) months; 83 patients (91.2%) were followed up, of whom 37
(44.58%) experienced a recurrence at a mean (SD) of 55.46 (36.79) months after surgery
(range, 9-140months). The recurrence in the SSIS site at a mean (SD) of 48.25 (29.94)
months after surgery affected 24 of 83 patients (28.9%), 9 beingmedical and 15 being
surgical recurrence. Recurrence in the SSIS was statistically significantly associated with the
time elapsed between diagnosis and surgery (P = .03). A borderline association between
family history of CD and surgical recurrence (P = .054) was also found. Multivariate analysis
identified the age at diagnosis (χ2 = 5.56; P = .02) and at surgery (χ2 = 7.77; P = .005), family
history (χ2 = 6.26; P = .01), and smoking habit (χ2 = 10.06; P = .007) as independent risk
factors for recurrence.
CONCLUSIONS AND RELEVANCE In the short-term, SSIS leads to a resolution of symptoms in
more than 90% of cases and the recurrence rate in the SSIS area is acceptable, even after
long-term follow-up.
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T he surgical outcomeofCrohndisease (CD) is character-ized by recurrence even after “radical” operations,which remove both microscopically and macroscopi-
callyaffectedbowel.Althoughthesurgical approach in thepast
has been characterized by radical resections of the affected
areas, the present therapeutic approach is to perform conser-
vative operations and reduce the risk for short-bowel syn-
drome. Included in this approachare techniques suchasmini-
mal resectionandstrictureplasty (SXPL).LeeandPapaioannou
were the first to use SXPL in patients with CD in 1982.1 Over
the last 30 years, the SXPLmethod has further expanded and
been performed even in long strictures.
In 1996,Michelassi2 described a new type of SXPL known
as side-to-side isoperistaltic strictureplasty (SSIS). In 2000, a
variation in the original technique in the section of the neo-
terminal ileum and colic cul-de-sac at the level of a previous
side-to-side or end-to-side ileo-colic anastomosis performed
for CD was described by one of the authors (F.T.).3
In 2004, our center evaluated patients who had under-
gone SSIS, but at the time, the cases were still limited (n = 21)
and the follow-uprelatively short.4 In2007, a retrospectiveob-
servational, multicenter international study was conducted
with the purpose of assessing the results achieved with SSIS
in its first 10 years of use in treating CD. The evidence ob-
tainedprovedhowitcouldbeconsideredasafe technique,with
very lowmorbidity andmortality rates and an acceptable risk
for recurrence.5
Because the evaluation of risk factors implicated in the
recurrence of CD in the strictureplasted bowel is still
extremely limited, the purpose of this study was to evaluate
the results obtained in a large population of patients with CD
who have undergone SSIS, after long-term follow-up, and
especially to identify possible recurrence-related factors at
the SSIS site.
Methods
FromAugust 1996 toMarch2010, 91patientswithCD (48men
and43women;median age, 39 years; range, 20-71 years) con-
secutively underwent SSIS in our center; the operationswere
performed by the same surgeon. The study was approved by
the localethicscommitteeofAziendaOspedalieraCareggi.Oral
informed consent was obtained from the study participants.
At the timeof first surgery, 34 patientswere smokers, 23were
former smokers, and 34 had never smoked. Themain indica-
tion for surgery was bowel obstruction in 68 cases, malnutri-
tion in 11 patients, and fistula and/or abscess in 12 patients. Of
those patients with fistulizing CD, 7 had entero-enteric fistu-
lae, 1 had entero-colic fistulae, 2 had entero-sigmoideal fistu-
lae, and 3 had multiple fistulae (between the ileum and the
bladder, vagina, skin, colon, and sigma). Seven of these pa-
tients alsohadanabscess:mesenteric in5, pelvic in 1, andnear
the bladder in 1.
Fifty-two patients had already undergone 1 (n = 30), 2
(n = 12), 3 (n = 4), 4 (n = 5), or 5 (n = 1) operations for CD.
Appendectomy had been previously performed in 17 patients.
A total of 94 SSISs had been performed, as 2 SSISs were car-
ried out simultaneously during the same operation in 3
patients. The clinical characteristics of the patients are shown
in Table 1.
Themean extent of diseased bowel was 69.97 cm (range,
20-150cm). Strictureswereclassifiedas short (≤6cmin length)
or long (>6 cm in length). The strictures involved in the SSIS
were long and continuous in 18 patients, short and multiple
in 54, and both short and long in 19. Themedian length of the
long continuous strictureswas 15 cm (range, 7-80 cm) and2.5
Table 1. Demographics and Clinical Characteristics of the Patients
Characteristic No. (%)
Age, mean (SD), y 39.5 (11.2)
Preoperative disease duration, mean (SD), mo 97.9 (85.8)
Age at diagnosis, mean (SD), y 29 (11.2)
Sex
Male 48 (52.7)
Female 43 (47.3)
Family history of IBD
Yes 18 (19.8)
No 73 (80.2)
Smoking habit
Yes 34 (37.4)
No 34 (37.4)
Former smoker 23 (25.2)
Disease location
Duodenum-jejunum 5 (5.5)
Jejunum-ileum 40 (44)
Distal ileum-colon 46 (50.5)
Associated perianal disease
Yes 16 (17.5)
No 75 (82.5)
Abdominal fistula/abscess
Yes 12 (13.2)
No 79 (86.8)
Associated disease
Celiac disease 3 (3.3)
Hepatitis 4 (4.4)
Osteopenia/osteoporosis 2 (2.2)
Psoriasis 2 (2.2)
Sacroileitis/polyarthritis 2 (2.2)
Nodosum erythema 1 (1.1)
Recurrent venous thrombosis 2 (2.2)
Cholelithiasis 1 (1.1)
More than 1 of the above 4 (4.4)
Malnutrition
Yes 39 (42.8)
No 45 (57.2)
Preoperative therapy
5-ASA ± CCS 56 (61.5)
Immunosuppressants 28 (30.8)
Biological therapies 7 (7.7)
Abbreviations: 5-ASA, 5-amino-salicylic acid; CCS, corticosteroids;
IBD, inflammatory bowel disease.
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cm for the short ones (range, 0.5-6 cm). The median thick-
ness of the intestinal wall at the section where the SSIS was
performedwas 8.5mm (range, 5-16mm). Themean length of
residual small bowel was 263.53 cm (range, 120-450 cm).
Surgical Technique
Side-to-side isoperistaltic strictureplastywasperformedwith
the technique described byMichelassi in 1996 in 69 patients,
whereas we used the previously described personal tech-
nique in the remaining 22 patientswho had an ileal relapse at
a previous ileo-colic anastomosis.2,3
Side-to-side isoperistaltic strictureplasty was performed
at the level of the duodenum-jejunum in 5 patients, at the je-
juno-ileum in40patients, andon thedistal ileum-colon in46
patients.
The median length of the diseased bowel where the SSIS
was performed was 55 cm (range, 10-140 cm), and the me-
dian length of the SSIS was 28.41 cm (range, 8-72 cm). A syn-
chronous intestinal resectionwas necessary in 41 patients; in
28 of these, the diseased bowel resected was located in the
middleof the tractwhereSSIShadtobeperformedwithamean
length of 28.5 cm (range, 3-92 cm). Resection was performed
atdifferentdisease locations cranially ordistally fromtheSSIS
site in the remaining 12 patients.
A total of 41 patients had undergone additional SXPLs (16
singles and 25 multiples, up to a maximum of 11). The fistu-
lizingdiseasedbowelwas resected in6,whereas the fistulawas
suturedwithout resection in5patients.Abdominalabscesswas
drained intraoperatively in 4 of 7 patients, whereas the ab-
scesseswere included in the resection in the remaining3. Side-
to-side isoperistaltic strictureplasty was performed together
with appendectomy in 12 cases, cholecystectomy in 2 cases,
hemicolectomy in 2 cases, and a subtotal colectomy in 1 case.
Every patient was biopsied to exclude the presence of neo-
plastic tissue at the SSIS site.
Early Postoperative Treatment
At discharge, 5-amino-salicylic acid (5-ASA) by mouth was
prescribed, while corticosteroid therapy administered pre-
operatively was gradually decreased. No prophylactic immu-
nosuppressive or biological therapy were scheduled in these
patients.
Follow-up
Patients were scheduled for outpatient clinical assessment 1,
3, 6, and 12 months and then every 6 months following sur-
gery to evaluate the symptoms, bowelhabit, bodyweight, and
results of laboratory examinations and imaging studies
performed.
We considered CD recurrence to be the relapse of disease
symptoms in thepresenceof radiologically and/or endoscopi-
cally confirmed stricturing and/or inflammatory lesions re-
quiring medical treatment or surgery.
Statistical Analysis
Statistical analysis was carried out using the STATGRAPHICS
CenturionXVstatistical package (StatPoint Inc) and theuseof
GRAPHPAD Prism 5 software. Differences in the distribution
of each variable among patients in the recurrence and nonre-
currence categories were evaluated using the χ2 test or t test,
as appropriate.
The recurrence-free curve was estimated using Kaplan-
Meier analysis of different outcomes. Patients were stratified
into cohorts in relation to the considered categorical vari-
ables and data were compared using the Mantel-Cox log-rank
test. Cox proportional hazard regression analysis was used to
set up a predictive model simultaneously exploring the
effects of all independent variables on a dichotomous out-
come recurrence in relation to time (dependent variable val-
ues: censored/complete). The quantitative variables were
transformed into dichotomous categorical ones, and hazard
ratios (HRs) and 95% CIs were calculated using standard
methods.
The univariate analysis included the following indepen-
dentvariables: patient factors (sex, age atdiagnosis andat sur-
gery, smoking habits, number of cigarettes per day, years of
smoking, and family history of inflammatory bowel disease
[IBD]); disease factors (time between diagnosis and first sur-
gery, number of previous surgical procedures, presenceof fis-
tulaeand/orabscesses, andpresenceofassociatedperianaldis-
eases); surgery factors (technique,numberof strictures inSSIS,
numberofSXPLs, final lengthof theSSIS,disease location, and
associated appendectomy); pharmacological therapy factors
(presurgical andpostsurgical therapy); andperioperative fac-
tors (blood transfusions and total parenteral nutrition). Other
preoperative factors included the presence of anemia, in-
crease in inflammatory indexes, and malnutrition.
All the independent variables of the univariate analysis
were forced in the Cox proportional hazardmodel with back-
ward elimination applied to select themost promising subset
of predictors by multiple regression.
Results
None of the 91 patients died during surgery but 24 experi-
enced postoperative complications. Four patients had an
enterorrhagia between the third and eighth postoperative
days treated with medical therapy and 1 developed a hema-
toma in the rectal abdominal muscles that was drained percu-
taneously. One patient had anastomotic dehiscence of the
SSIS; another patient had dehiscence of associated restricture-
plasty (Heineke-Mikulicz [HM]) SXPL. Both patients were
reoperated on the second and seventh postoperative days
with suture of the dehiscence and peritoneal toilette, respec-
tively. One patient had dehiscence of 2 associated short SXPLs
with peritonitis requiring ileal resection and temporary termi-
nal ileostomy. One patient had a pelvic abscess treated with
computed tomography–guided drainage.
Ten patients had a bloodstream infection from the cen-
tral venous catheter, 3 patients developed suppuration of the
surgicalwound,and2caseshadprolongedpostoperativepara-
lytic ileum.
Patients’ intestinal activity restartedbetweenthe thirdand
13th postoperative days (mean, day 5), and nutrition was re-
sumed gradually from postoperative day 2.
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The median postoperative stay was 12 days (range, 7-87
days); 13 patients needed 1 ormore blood transfusions due to
serious anemia, 6 of whom during the preoperative period, 6
during the postoperative period, and 1 during surgery.
After surgery, all patients had resolution of obstructive
symptoms. During the third month after surgery, 85% of pa-
tients (n = 77)had increasedbodyweight, and68%(n = 62)ex-
perienced normalization of inflammation indexes. Obstruc-
tive symptoms relapsedwithin2weeks after discharge inonly
1 patientwhowas rehospitalized and the symptomswere con-
servatively treated with medical therapy.
Seven of 91 patients (7.7%) died owing to causes not re-
lated to CD during the follow-up.
Eightpatientswere lost to follow-up.The remaining83pa-
tients were regularly followed upwith laboratory and instru-
mental tests.Themeandurationof follow-upwas85.97months
(range, 6-180months).
During long-term follow-up,most patients reported 1 to 2
semisolid evacuations per day. Five patients (without recur-
rence)had3to4evacuationsperdaywithmildabdominalpain.
Eleven patients were treated with 5-ASA, 23 with 5-ASA
associated with corticosteroids, 19 with immunosuppres-
sants, 20 with biological drugs (anti–tumor necrosis factor
α), and 10 patients with a combination of all the previous
drugs. A total of 47 patients periodically took vitamins, folic
acid, and probiotics. Four patients developed iron-defi-
ciency anemia.
Recurrence
Among the 83 patients regularly followed up, 37 (44.6%) had
a clinical recurrence at a mean (SD) of 55.46 (36.79) months
after surgery (range,9-140months).Global recurrencewascon-
trolledwithmedical therapy in 15 patients (40.5%) and surgi-
cally (reoperation) in 22 (59.5%).
The recurrent diseasewas outside of the SSIS site in 13 pa-
tients (15.7%), being medical in 6 cases and surgical in 7
patients.
In the other 24 patients (28.9%), recurrence occurred
after a mean of 48.25 months (range, 9-140 months) inside
the SSIS site, being medical in 9 and surgical in 15 patients.
The surgical recurrence affected the SSIS body in 8 patients
(in 2 with long stricture and in 6 with short ones), the inlet in
4 patients, and the outlet in 3 cases; it was treated with SSIS
removal in 2 cases (both affected by more than 2 long stric-
tures at SSIS body) and strictureplasty (HM) of the stricture in
13 patients.
Twelve patients (50%) of 24 experienced recurrence after
more than 5 years, during which they experienced well-being
and good condition.
Recurrence-Related Risk Factors
Thepostoperative global recurrence and the surgical ormedi-
cal recurrence at the SSIS site were analyzed (Table 2).
The frequency of global recurrence was lower in former
smokerscomparedwithactivesmokersor thosewhohadnever
smoked (P < .01). Those with recurrence also had a signifi-
cantly shorter timebetweendiagnosis andsurgery (mean [SD],
55.46 [36.79] vs 122.30 [17.20] months; P = .02).
Patients with recurrence received postoperative therapy
thatwas significantlydifferent; inparticular,noneof themhad
received mesalazine alone while most of them had therapies
with corticosteroids, immunosuppressant drugs, or biologi-
cal therapies.
Moreover, recurrent patients had a family history of CDor
IBDathigher frequencycomparedwith thenorecurrencecases
(32.4%vs 13%) but this differencedidnot reach statistical sig-
nificance (P = .06).
Instead,patientswith surgical recurrence inSSIShada sig-
nificantly shorter time between diagnosis and surgery
(P = .002).
The estimation of the actuarial curves according to the
Kaplan-Meier method was calculated with the log-rank test to
evaluate the relationship between the examined variables and
postoperative recurrence. The global risk for recurrence was
moderately lower in patients without family history of CD
(HR, 0.45; P = .06) and higher for those with diseases located
in the jejunum-ileum compared with the distal ileum-colon
localizations (HR, 2.45; 95% CI, 1.15-5.22; P = .002) (Figure,
A; Table 3). Moreover, former smokers had a significantly
lower risk for recurrence compared with smokers and those
patients who had never smoked (Figure, A). When analyzing
the risk factors associated with surgical recurrence in SSIS
alone, we found a reduced risk in patients without a family
history of CD (HR, 0.13; P = .006) and with a disease local-
ization in the distal part of the small bowel (HR, 0.23;
P = .002) (Figure, B).
Multivariate analysis identifiedageatdiagnosis (χ2 = 5.56;
P = .02) and at surgery (χ2 = 7.77; P = .005), family history
(χ2 = 6.26; P = .01), and smoking habit (χ2 = 10.06; P = .007)
as independent risk factors forpostoperative recurrence.These
risk factorsweremore relevant inmenbecause inwomen, the
only statistically significant risk factor was age at surgery
(Table 4).
Discussion
Our study indicated that the following factorswere related to
global recurrence of CD in our patients who had undergone
SSIS: smoking habit, a short time between diagnosis and sur-
gery, andpostoperative therapy.Moreover, a family history of
IBD was a borderline risk factor.
It is of interest that former smokers (patients who had
stopped smoking after surgery) had a significantly lower re-
currence rate. Cigarette smoking is considered both an etio-
logical risk factor for thedisease aswell as its recurrence,with
studies showing that smokers not only have a higher risk for
developing a postoperative recurrence compared with non-
smokers (around 2.5 times more), but also that this risk in-
creases in relation to the number of cigarettes smoked (espe-
cially for heavy smokers, >10 cigarettes a day).6-10 Our data
suggest that smoking probably plays a decisive role in the de-
velopment of CDbutwhen these patients quit, theymayhave
significantly reduced the risk for recurrence, as the “aggres-
siveness” of the disease in their case may have been strongly
influencedbysmoking.Literatureevidence is rareonthispoint,
Results and Risk Factors of Side-to-Side Isoperistaltic Strictureplasty in Crohn Disease Original Investigation Research
jamasurgery.com (Reprinted) JAMA Surgery May 2016 Volume 151, Number 5 455
Downloaded From: http://archsurg.jamanetwork.com/ by a UNIEVERSITA DEGLI STUDI DI FIRENZE User  on 08/05/2016
Copyright 2016 American Medical Association. All rights reserved.
Table 2. Univariate Analysis of Variables in Relation to Postoperative Recurrence in 83 Patientsa
Variable
No. (%)
Cases SSIS
No Recurrence
(n = 46)
Recurrence
(n = 37)
Recurrence
(n = 24)
Surgical
Recurrence
(n = 15)
Sex
Male 26 (56.5) 18 (48.6) 11 (45.8) 8 (53.3)
Female 20 (43.5) 19 (51.4) 13 (54.2) 7 (46.7)
Age at surgery, mean (SD), y 41.22 (1.71) 37.02 (1.74) 39.38 (2.34) 40.27 (2.47)
Age at diagnosis, mean (SD), y 31.48 (1.63) 30.10 (1.96) 32.46 (2.81) 33.00 (2.97)
Family history of IBD
Yes 6 (13.0) 12 (32.4) 7 (29.2) 6 (40.0)
No 40 (87.0) 25 (67.6) 17 (70.8) 9 (24.3)
Smoking habit
Yes 15 (32.6) 18 (48.6)b 11 (45.8) 7 (46.7)
No 14 (30.4) 16 (43.2)b 10 (41.7) 6 (16.2)
Former smokers 17 (37.0) 3 (8.1)b 3 (12.5) 2 (13.3)
No. of cigarettes/d (in smokers),
mean (SD), y
16.38 (3.13) 18.28 (2.86) 15.91 (2.98) 14.86 (2.47)
Duration of smoking (in
smokers), mean (SD), y
19.00 (2.31) 17.11 (2.37) 17.64 (3.42) 14.86 (3.13)
Quit smoking after surgery
(in smokers)
Yes 3 (23.1) 4 (23.5) 3 (27.3) 1 (14.3)
No 10 (76.9) 13 (76.5) 8 (72.7) 6 (85.7)
Time between diagnosis and
surgery, mean (SD), mo
122.30 (17.20) 55.46 (36.79)c 48.25 (29.94)c 53.6 (16.4)c
No. of previous surgical
procedures
0-1 37 (80.4) 26 (70.3) 17 (70.8) 10 (66.7)
≥2 9 (19.6) 11 (29.7) 7 (29.2) 5 (13.5)
Perianal disease
Yes 7 (15.2) 7 (18.9) 4 (16.7) 3 (20.0)
No 39 (84.8) 30 (81.1) 20 (83.3) 12 (80.0)
Presence of fistulae and/or
abscesses
Yes 9 (19.6) 3 (8.1) 1 (4.2) 0
No 37 (80.4) 34 (91.9) 23 (95.8) 15 (100)
Surgical technique
SSIS 14 (30.4) 10 (27) 7 (29.2) 4 (26.7)
Resection+SSIS 14 (30.4) 9 (24.3) 5 (20.8) 4 (26.7)
Resection+SXPL+SSIS 11 (23.9) 9 (24.3) 6 (25.0) 5 (33.3)
SSIS+SXPL 7 (15.2) 9 (24.3) 6 (25.0) 2 (13.3)
Resection
Within SSIS 14 (41.2) 14 (37.8) 10 (43.5) 9 (60.0)
No resection 20 (58.8) 19 (51.4) 13 (56.5) 6 (40.0)
No. of strictures in SSIS
1 14 (30.4) 11 (29.7) 7 (29.2) 3 (20.0)
2 6 (13.0) 3 (8.1) 2 (8.3) 1 (6.7)
3-5 12 (26.1) 6 (16.2) 3 (12.5) 2 (13.3)
6-10 10 (21.7) 12 (32.4) 9 (37.5) 7 (46.7)
11-20 4 (8.7) 5 (13.5) 3 (12.5) 2 (13.3)
No. of SXPLs
0 28 (60.9) 19 (51.4) 12 (50.0) 8 (53.3)
1-2 11 (23.9) 13 (35.1) 8 (33.3) 4 (26.7)
>2 7 (15.2) 5 (13.56) 4 (16.7) 3 (20.0)
(continued)
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and themost recent contributions do not seem to show a sig-
nificantdifferencebetweenformersmokersandnonsmokers.11
Sex, age at diagnosis or surgery, number of previous op-
erations,durationof thedisease, localizationof thediseaseand
of the SSIS, number of strictures and associated small-bowel
resection within the SSIS, other resections, perianal CD, fis-
tulizing disease, anemia, inflammatory index, blood transfu-
sion,andmalnutritionor totalparenteralnutritiondidnotseem
related to recurrence.
Univariate analysis of patientswithmedical or surgical re-
currenceat theSSIS site identified similar risk factors: the time
betweendiagnosis and surgery and thepostoperative therapy.
Specifically, patientswith a surgical recurrence in theSSIS site
showeda significantly shorter timebetween thediagnosis and
surgery (mean [SD], 45.64 [13.01] comparedwith 122.3 [17.20]
months for patientswithout recurrence). This findingwasnot
unexpectedbecausepatients undergoing surgerywith a short
time between diagnosis and surgery usually have a more ag-
gressive form of the disease.
We observed that the risk for relapse was significantly
lower in patients without a family history of IBD; 35.7% of
the SSIS patients who had a surgical recurrence also had a
family history of IBD compared with 13% of the no recur-
rence cases.
Another risk factor seems to be the disease location, with
an increased recurrence in patients with the disease located
in the upper part of the intestine (2.5-fold higher) than those
with diseases located in the distal ileum and colon.12-14
Aprevious retrospectivestudybyGreensteinetal15 in2009
found that the number of strictures and SXPLs was associ-
ated with postoperative recurrence risk. However, the au-
thors examined only HM and/or Finney SXPLs. Our data sug-
gest that the situation is different for SSIS because a higher
number of strictures found on the SSIS segment (11-20 steno-
sis) is not related to a higher rate of recurrence.
The association between age at diagnosis or at first sur-
gery and recurrence risk is still controversial16,17; our data
indicated that the age at diagnosis or at surgery are indepen-
Table 2. Univariate Analysis of Variables in Relation to Postoperative Recurrence in 83 Patientsa (continued)
Variable
No. (%)
Cases SSIS
No Recurrence
(n = 46)
Recurrence
(n = 37)
Recurrence
(n = 24)
Surgical
Recurrence
(n = 15)
Final length of the SSIS, mean
(SD), cm
49.45 (14.6) 52.98 (14.9) 54.60 (15.6) 59.10 (16.8)
Disease location
Duodenum-jejunum 2 (4.3) 3 (8.1) 3 (12.5) 2 (13.3)
Jejunum-ileum 16 (34.8) 16 (43.2) 10 (41.7) 7 (46.7)
Ileum-colon 28 (60.9) 18 (48.6) 11 (45.8) 6 (40.0)
Appendectomy
Yes 8 (17.4) 8 (21.6) 7 (29.2) 4 (26.7)
No 38 (82.6) 29 (78.4) 17 (70.8) 11 (73.3)
Anemia
Yes 21 (48.8) 17 (45.9) 13 (54.2) 8 (53.3)
No 22 (51.2) 19 (51.4) 11 (45.8) 7 (46.7)
Inflammatory indexes
Yes 17 (39.5) 18 (48.6) 13 (54.2) 10 (66.7)
No 26 (60.5) 19 (51.4) 11 (45.8) 5 (33.3)
Malnutrition
Yes 24 (52.2) 15 (40.5) 11 (45.8) 8 (53.3)
No 22 (47.8) 22 (59.5) 13 (54.2) 7 (46.7)
Blood transfusions
Yes 8 (17.4) 5 (13.3) 2 (8.3) 2 (13.3)
No 38 (82.6) 32 (86.7) 22 (91.7) 13 (86.7)
Total parenteral nutrition
Yes 25 (55.6) 22 (59.5) 13 (54.2) 9 (64.3)
No 20 (44.4) 14 (37.8) 11 (45.8) 5 (35.7)
Postoperative use
Mesalazine 11 (23.9) 0 (0.0)d 0 (0.0)b 0 (0.0)c
CCS+mesalazine 11 (23.9) 12 (32.4)d 8 (33.3)b 6 (40.0)c
Immunosuppressant 10 (21.7) 9 (24.3)d 7 (29.2)b 3 (20.0)c
Biological therapies 5 (10.9) 15 (40.5)d 9 (37.5)b 6 (40.0)c
Others 9 (19.6) 1 (2.7)d 0 (0.0)b 0 (0.0)c
Abbreviations: CCS, corticosteroids;
IBD, inflammatory bowel disease;
SSIS, side-to-side isoperistaltic
strictureplasty; SXPL, strictureplasty.
a Differences in the distribution of
variables among patients with and
without recurrences were evaluated
using the χ2 test or 1-way analysis of
variance, as appropriate.
bP < .01.
c P < .05.
dP < .001 vs no recurrence cases.
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dent risk factors only in men. Our results showed a lower per-
centage of global recurrence and surgical recurrence in
patients treated with 5-ASA alone after surgery compared
with those treated with corticosteroids, immunosuppres-
sants, or anti–tumor necrosis factor α drugs. This is likely
because 5-ASA alone was administered only in patients with
no symptoms or mild disease, while immunosuppressive or
biological therapies were administered in the presence of
Figure. Kaplan-Meier Time-to-Event Estimate Plots
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A, Global recurrence based on family history, smoking, and disease location.
Recurrence events were significantly negatively associated with cessation of
smoking (P < .05) and with distal ileum-colon localization of the disease
(P < .01). B, Surgical recurrence in side-to-side isoperistaltic strictureplasty
(SSIS) based on family history of inflammatory bowel disease and disease
location. Surgical recurrence in SSIS alone was associated with significant
reduction in patients without a family history and with a disease localization in
the distal part of the bowel.
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clinical relapse. However, 10 patients treated with a combina-
tion of all the drugs did not show any recurrence.
Manyprospective studies18-21 ormeta-analysis22 evaluat-
ing global CD recurrence after ileo-cecal resection are present
but clinical trials evaluating the efficacyof prophylacticmedi-
cal therapies in reducing postoperative recurrence after SSIS
are still lacking.
Only a randomized study by Ardizzone et al23 evaluated,
after conservative surgery (SXPL or minimal resection), the
postoperative prophylactic use of azathioprine, showing af-
ter 24 months of follow-up that there was no significant dif-
ference in terms of clinical and surgical recurrence compared
with the control group treated with 5-ASA.
Only rarely is theredescribedanassociationbetweencan-
cer and SXPL24-26 and in the present study, we had no case of
intestinal cancer inSSIS,evenaftera long-termfollow-up.How-
ever, careful surveillance of these patients is desirable.
Side-to-side isoperistaltic strictureplasty can be consid-
ered a useful alternative to resection, especially in extended
or multioperated on patients with CD whomight have short-
bowel syndrome.
Currently, to our knowledge, there are no standard indi-
cations for SSIS and, therefore, the experience of the surgeon
plays a fundamental role. Studies carried out so far, aiming at
identifying specific risk factors associatedwith recurrences in
patients treated with SSIS, have not provided homogeneous
results.5,6,17,26,27 Furthermore, these fewstudies, owing to the
relatively recent introduction of SSIS, included small cohorts
of patients. Our relatively long experience with this tech-
nique, performed formore than 15 years, provides uswith the
opportunityof evaluatingpossible recurrence risk factorsover
long-term follow-up.
Furthermore, our data are discordant regarding previous
experiences28,29 about the site of the surgical recurrence in
SSIS. In 8 of our patients (53.7%), the recurrence affected the
bodyof theSSIS,whichwas successfully treatedwithHMstric-
tureplasty in 75% of them.
Moreover,we followedupbyendoscopy thepatientswith
an SSIS on the neoterminal ileum andwe observed normal or
milderythematousmucosa inmostof thesepatients.With time
only, 27.3% (6 of 22 patients who had undergone SSIS on the
neoterminal ileum) of them developed mucosal edema with
aphthaeorulcers andsubsequently stricture that required sur-
gical treatment only in 2 cases.
A possible limitation of the study is the lack of uniformity
in the postoperative medical therapy.
Conclusions
Our work shows that SSIS, in the short-term, leads to a reso-
lution of symptoms in more than 90% of cases; only 5 pa-
tients (6%) all with a strictureplasted small bowel wider than
70cmrequireda longer follow-up for resolutionof anemia.We
havenoticed that some factors influence the recurrenceof the
disease, including the habit of cigarette smoking and the age
at diagnosis, especially in men. A family history of IBD is an-
other positive correlation with recurrence risk, as is the loca-
tion of the disease in the upper part of the bowel. The other
examined factors did not show any significance, but in some
cases, this could depend on the relatively small size of our
sample.
Table 3. Global Recurrence-Free Survivala
Variable HR (95% CI) P Value
Sex
Male vs female 0.93 (0.48-1.79) .83
Age at diagnosis, y
< 30 vs > 30 1.66 (0.85-3.22) .14
Age at surgery, y
< 40 vs > 40 1.61 (0.82-3.18) .17
Family history of IBD
No vs yes 0.45 (0.20-1.03) .06
Smokers vs nonsmokers
Yes vs no 0.82 (0.41-1.66) .59
Yes vs former smokers 3.16 (1.26-7.95) .01
No vs former smokers 3.51 (1.44-8.57) .006
No. of cigarettes/d
No smoking vs <15 1.15 (0.47-2.86) .76
No smoking vs >15 0.98 (0.40-2.38) .97
Duration of smoking, y
No smoking vs <20 1.49 (0.70-3.19) .30
No smoking vs >20 0.75 (0.26-2.12) .59
Quit smoking after surgery
No smoking vs yes 1.15 (0.37-3.62) .81
No. of previous surgical procedures
0 vs ≥1 0.86 (0.44-1.66) .64
Perianal disease
No vs yes 0.75 (0.30-1.87) .54
Disease location
Jejunum-ileum vs ileum-colon 2.45 (1.15-5.22) .002
Inflammatory indexes
No vs yes 0.70 (0.35-1.39) .30
Abbreviations: IBD, inflammatory bowel disease; HR, hazard ratio.
a Calculated using actuarial (Kaplan-Meier) analysis with follow-up time (time at
risk) beginning at first reoperation or at last available follow-up.
Table 4. Independent Risk Factors for Postoperative Recurrence
Factor χ2 P Value
Age at surgery 7.77 .005
Age at diagnosis 5.56 .02
Family history of IBD 6.26 .01
Smoking habit 10.06 .007
Women
Age at surgery 5.52 .02
Men
Age at diagnosis 4.24 .04
Family history of IBD 7.89 .005
Smoking habit 12.63 .002
Abbreviation: IBD, inflammatory bowel disease.
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